Nephros, Inc.
NEPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $50 | $43 | $18 | $16 |
| - Cash | $5 | $5 | $4 | $4 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $46 | $40 | $15 | $13 |
| Revenue | $5 | $4 | $5 | $4 |
| % Growth | 7.8% | -9.4% | 26% | – |
| Gross Profit | $3 | $3 | $3 | $2 |
| % Margin | 61.2% | 63.2% | 64.7% | 64% |
| EBITDA | $0 | $0 | $1 | $0 |
| % Margin | 7.9% | 6.4% | 12.3% | 10.3% |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 7.1% | 5.4% | 11.4% | 9% |
| EPS Diluted | 0.03 | 0.022 | 0.053 | 0.033 |
| % Growth | 37% | -58.4% | 58.9% | – |
| Operating Cash Flow | $0 | $1 | $0 | $1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $1 | $0 | $1 |